NM_000249.4:c.447G>C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000249.4(MLH1):c.447G>C(p.Gln149His) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,460,750 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000249.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251418Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135888
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460750Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 726776
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Lynch syndrome Uncertain:1
- -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 149 of the MLH1 protein (p.Gln149His). This variant is present in population databases (rs63750638, gnomAD 0.006%). This missense change has been observed in individual(s) with colorectal cancer (PMID: 17440950). ClinVar contains an entry for this variant (Variation ID: 90220). Invitae Evidence Modeling incorporating data from in vitro experimental studies (internal data) indicates that this missense variant is not expected to disrupt MLH1 function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.Q149H variant (also known as c.447G>C), located in coding exon 5 of the MLH1 gene, results from a G to C substitution at nucleotide position 447. The glutamine at codon 149 is replaced by histidine, an amino acid with highly similar properties. This alteration was detected in one individual, diagnosed with colon cancer at age 34, whose tumor demonstrated absence of the MLH1 protein and negative MLH1 promoter methylation (Ewald J et al. Br J Surg, 2007 Aug;94:1020-7). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. In addition, this alteration is predicted to be benign by MAPP-MMR in silico analyses (Chao EC et al. Hum. Mutat. 2008 Jun;29:852-60). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at